RIT1-mediated Protection following Traumatic Brain Injury
RIT1 介导的脑外伤后保护
基本信息
- 批准号:10352301
- 负责人:
- 金额:$ 50.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Traumatic brain injury (TBI) is a major cause of death and permanent disability in the United States affecting
more than 1.7 million individuals each year. TBI not only results in tissue damage and cell death, but can
perturb surviving neuronal function, leading to alterations in neural connectivity, abnormal plasticity, and
network dysfunction. Due to the inherent diversity in post-TBI dysfunction, a critical need exists for therapeutic
interventions that target multiple injury mechanisms. Development of such multi-prong therapeutic approaches
could have enormous clinical, social, and economic benefit. However, implementation of this strategy requires
the identification of endogenous molecular cascades capable of regulating multiple protective/restorative
pathways. The discovery that the Rit GTPase (RIT1) is dramatically down-regulated following cortical
contusion injury (CCI) prompted studies to explore the contribution of Rit-directed signaling to functional
recovery following TBI. Drawing upon a collection of RIT1 transgenic mice, exciting preliminary data
demonstrate that Rit activation reduces in vivo neurodegeneration and alleviates cognitive dysfunction
following CCI. Additional data suggest that Rit is critical for post-TBI neurogenesis and promotes synaptic
integrity by reducing post-contusion synaptic loss. Collectively these data are the first to demonstrate a
significant role for Rit in directing neuroprotection and neuroplasticity following TBI, and suggest that Rit
functions as a linchpin regulator of multiple injury response mechanisms following CCI. The overall hypothesis
is that: (1) Rit plays a key role in cellular and functional recovery from brain trauma, and (2) that activation of
Rit signaling therefore has broad therapeutic potential in the setting of TBI. Three complementary aims guide
our studies. Aim 1 will test the hypothesis that contusion-dependent Rit loss disrupts gene expression
programs that promote neural survival and neurogenesis. In Aim 2 we will evaluate the extent to which Rit
signaling controls neuronal survival after contusive brain injury. The efficacy of Rit-targeted therapies will be
evaluated using an inducible knock-in mouse model to permit Rit activation over a clinically relevant period of
hours to days after the onset of brain injury. Aim 3 will test the hypothesis that Rit signaling preserves synaptic
function following traumatic brain injury using transgenic mice, electrophysiology, and biochemical assays.
Overall, these studies are expected to identify Rit as a crucial signal integration hub in the setting of brain injury
– orchestrating diverse endogenous pathways that regulate neuronal survival, promote neuronal regeneration,
and control neuroplasticity mechanisms.
创伤性脑损伤(TBI)是美国影响的主要原因和永久性残疾
每年超过170万人。 TBI不仅会导致组织损伤和细胞死亡,而且可以
在神经元功能中存活的驱动性,导致神经元连通性,可塑性异常和
网络功能障碍。由于TBI后功能障碍的继承多样性,对治疗存在关键需求
针对多种伤害机制的干预措施。开发这种多泛力治疗方法
可能具有巨大的临床,社会和经济利益。但是,实施此策略需要
鉴定能够调节多重保护/恢复的内源性分子级联
途径。皮质后,RIT GTPase(RIT1)的发现急剧下调
挫伤损伤(CCI)促使研究探讨了RIT指导信号对功能的贡献
TBI后的恢复。利用RIT1转基因小鼠的集合,令人兴奋的初步数据
证明RIT激活减少体内神经变性并减轻认知功能障碍
遵循CCI。其他数据表明,RIT对于TBI后神经发生至关重要,并促进突触
通过降低结合后的合成损失来完整性。这些数据集体是第一个证明
RIT在TBI后指导神经保护和神经塑性的重要作用,并表明RIT
在CCI后充当了多个损伤反应机制的关键调节剂。总体假设
是:(1)RIT在脑创伤中的细胞和功能恢复中起关键作用,(2)激活
因此,RIT信号在TBI的环境中具有广泛的治疗潜力。三个完整的目标指南
我们的研究。 AIM 1将检验以下假设:挫伤依赖性RIT损失会破坏基因表达
促进神经存在和神经发生的程序。在AIM 2中,我们将评估多大程度的程度
信号传导控制连续脑损伤后神经元存活。以RIT为目标的疗法的效率将是
使用诱导的敲入小鼠模型进行评估以允许在临床相关的时期内激活RIT
脑损伤发作后数小时。 AIM 3将测试RIT信号传导可保留突触的假设
使用转基因小鼠,电生理学和生化测定后,脑外伤后的功能。
总体而言,这些研究有望将RIT识别为脑损伤的关键信号整合中心
- 策划调节神经元存活的内源性途径,促进神经元再生,
并控制神经塑性机制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Douglas Allen Andr...的其他基金
G Protein Signaling in Brain Injury
脑损伤中的 G 蛋白信号转导
- 批准号:1062668110626681
- 财政年份:2022
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Monomeric G-proteins and Cardioprotection from Heart Failure
单体 G 蛋白和心力衰竭的心脏保护作用
- 批准号:97621889762188
- 财政年份:2017
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Monomeric G-proteins and Cardioprotection from Heart Failure
单体 G 蛋白和心力衰竭的心脏保护作用
- 批准号:92367309236730
- 财政年份:2017
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Monomeric G-proteins and Cardioprotection from Heart Failure
单体 G 蛋白和心力衰竭的心脏保护作用
- 批准号:93364239336423
- 财政年份:2016
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Regulation of Neuronal Survival by Ras-like GTPase
Ras 样 GTP 酶对神经元存活的调节
- 批准号:70686187068618
- 财政年份:2003
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Regulation of Neuronal Survival by Ras-like GTPase
Ras 样 GTP 酶对神经元存活的调节
- 批准号:67515786751578
- 财政年份:2003
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Regulation of Calcium Channel Function by the Rem GTPase
Rem GTPase 对钙通道功能的调节
- 批准号:67369386736938
- 财政年份:2003
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Regulation of Calcium Channel Function by the Rem GTPase
Rem GTPase 对钙通道功能的调节
- 批准号:84641878464187
- 财政年份:2003
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Regulation of Neuronal Survival by the Rit GTPase
Rit GTPase 对神经元存活的调节
- 批准号:82746838274683
- 财政年份:2003
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Regulation of Calcium Channel Function by the Rem GTPase
Rem GTPase 对钙通道功能的调节
- 批准号:82815088281508
- 财政年份:2003
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
相似国自然基金
区域医疗一体化对基层医疗机构合理用药的影响及优化策略——基于创新扩散理论
- 批准号:72304011
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
高温与臭氧复合暴露对我国心脑血管疾病寿命损失年的区域分异影响及未来风险预估研究
- 批准号:42305191
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
纳米结构和低压协同影响下接触线区域蒸发液体的界面作用和界面传递特性
- 批准号:52376053
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
碳边境调节机制对我国区域经济、社会和环境协调发展的影响——考虑企业所有制异质性的研究
- 批准号:72303240
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
太平洋和大西洋年代际海温模态对大湄公河次区域夏季降水变化的协同影响研究
- 批准号:42375050
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Mitochondrial Calcium and Neuronal Health
线粒体钙和神经元健康
- 批准号:1063886910638869
- 财政年份:2023
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
A rigorous test of dual process model predictions for problematic alcohol involvement
对有问题的酒精参与的双过程模型预测的严格测试
- 批准号:1067925210679252
- 财政年份:2023
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:1070212610702126
- 财政年份:2023
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:1070130910701309
- 财政年份:2023
- 资助金额:$ 50.9万$ 50.9万
- 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:1064834610648346
- 财政年份:2023
- 资助金额:$ 50.9万$ 50.9万
- 项目类别: